ctDNA
ctDNA is an intervention with 12 clinical trials. Currently 6 active trials ongoing.
Success Metrics
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
0.0%
0 of 0 finished
0.0%
0 ended early
6
trials recruiting
12
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
ctDNA and Organ Preservation/Pathologic CR in Rectal Cancer
Disease Extent in Stage IV Lobular Carcinoma: the Aid of Imaging and Liquid Biopsy Analyses
Setting Up ctDNA Analysis on Archived Plasma Samples
Implementing ctDNA and Circular DNA in Patients With Localized Pancreatic Cancer
Exploration of Personalized Biomarkers During Neoadjuvant Radiation Therapy for Spinal and Sacral Chordoma
Clinical Trials (12)
ctDNA and Organ Preservation/Pathologic CR in Rectal Cancer
Disease Extent in Stage IV Lobular Carcinoma: the Aid of Imaging and Liquid Biopsy Analyses
Setting Up ctDNA Analysis on Archived Plasma Samples
Implementing ctDNA and Circular DNA in Patients With Localized Pancreatic Cancer
Exploration of Personalized Biomarkers During Neoadjuvant Radiation Therapy for Spinal and Sacral Chordoma
Monitoring Minimal Residual Disease in Gastric Cancer by Liquid Biopsy Study Description
Clinical Validation and Benchmarking of Top Performing ctDNA Diagnostics - Stage III NSCLC
Safe De-escalation of Chemotherapy for Stage 1 Breast Cancer
Predictive Value of ctDNA for NED Status in mCRC and Its Utility in Guiding Therapeutic Intervention
The Value of ctDNA on Chemotherapy Efficacy for mCRC
Heterogeneity and Evolution of hepatoceLlular Carcinoma in Post-transplant HCC Recurrence
Ovarium Cancer Detection by TEP's and ctDNA
All 12 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 12